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Autotaxin, a lysophospholipase D encoded by the
Enpp2 gene, is an exoenzyme that produces
lysophosphatidic acid in the extracellular space.
Lysophosphatidic acid acts on specific G protein-
coupled receptors, thereby regulating cell growth,
migration, and survival. Previous studies have revealed
that Enpp2-/- mouse embryos die at about E9.5 owing to
angiogenic defects in the yolk sac. However, what
cellular defects occur in Enpp2-/- embryos and what
intracellular signaling pathways are involved in the
phenotype manifestation remain unknown. Here, we
show that Enpp2 is required to form distinctive large
lysosomes in the yolk sac visceral endoderm cells. From
E7.5 to E9.5, Enpp2 mRNA is abundantly expressed in
the visceral endoderm cells. In Enpp2-/- mouse embryos,
lysosomes in the visceral endoderm cells are
fragmented. By using a whole embryo culture system
combined with specific pharmacological inhibitors for
intracellular signaling molecules, we show that
lysophosphatidic acid receptors and the Rho-ROCK-
LIM kinase pathway are required to form large
lysosomes. In addition, electroporation of dominant
negative forms of Rho, ROCK, or LIM kinase also
leads to the size reduction of lysosomes in wild-type VE
cells. In Enpp2-/- visceral endoderm cells, the steady-state
levels of cofilin phosphorylation and actin
polymerization are reduced. In addition, perturbations
of actin turnover dynamics by actin inhibitors
cytochalasin B and jasplakinolide result in the defect in
lysosome formation. These results suggest that
constitutive activation of the Rho-ROCK-LIM kinase
pathway by extracellular production of
lysophosphatidic acid by the action of autotaxin is
required to maintain large size of lysosomes in visceral
endoderm cells.
Autotaxin, also known as ENPP2 (ectonucleotide
pyrophosphatase/phosphodiesterase 2), is an extracellular
lysophospholipase D (lysoPLD) that produces
lysophosphatidic acid (LPA) (1-4). LPA is a lipid mediator
possessing a wide variety of biological functions, including
cell proliferation, migration, and survival (4-6). LPA
activates LPA1-6 receptors, which are coupled to several
downstream signals via at least 3 distinct G protein
subfamilies: G12/13, Gi, and Gq (4, 5, 7). Additionally, the role
of autotaxin in sphingosine 1-phosphate (S1P) production
was suggested in vitro, but remains to be established in vivo
(4, 8). Recently, it has been reported that Enpp2-/- mice died
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at embryonic day 9.5 (E9.5) owing to angiogenic defects in
the yolk sac (9, 10). Enpp2-/- embryos also showed allantois
malformation, neural tube defects, no axial turning, and
head enlargement, indicating the essential roles of Enpp2 for
mouse embryonic development (9, 10). Furthermore, adult
Enpp2-heterozygous mice showed half-normal levels of
lysoPLD activity and LPA, but normal levels of S1P, in
plasma, suggesting that autotaxin is a major LPA-producing
enzyme in vivo (9, 10). However, what cellular defects are
caused by the lack of LPA production in Enpp2-/- embryos
and what signaling pathways underlie the defects remain
elusive.
The extraembryonic visceral yolk sac is the first place
where hematopoiesis and vasculogenesis occur in the
mouse. It is composed of two layers, the visceral endoderm
(VE) and the underlying mesoderm layers. VE cells play a
critical role in the maternofetal exchange of nutrients prior to
the establishment of a chorioallantoic placenta (~E9). They
endocytose maternal proteins vigorously, hydrolyze the
proteins in lysosomes, and supply the resultant products to
the developing embryo (11, 12). Reflecting high endocytic
and digestive activity, VE cells are endowed with
dinstinctively large lysosomes (known as amorphous
vacuoles in electron microscopy) (11, 12). Blockade of VE
cell functions using chemicals, antibodies, or gene
disruption caused fetal malformation (11, 13), suggesting
the functional importance of VE cells in rodent
development.
Lysosomes are dynamic membrane-bound organelles
that receive and degrade macromolecules from endocytic,
phagocytic, and autophagic pathways (14, 15). They
undergo dynamic fusion/fission and yet cells maintain a
relatively constant size and number of lysosomes (14, 15).
Genetic studies in yeast and Drosophila as well as cell
biological studies in mammalian cells have identified many
intracellular components involved in the biogenesis of
lysosomes and vacuoles (yeast homologs of lysosomes)
and elucidated their functions (14, 15). However, it remains
unknown whether lysosome biogenesis is regulated by
extracellular signals and which signaling pathway(s), if any,
regulate the process.
In the present study, we show that Enpp2 mRNA is
highly expressed in the yolk sac VE cells from E7.5 to E9.5.
In the VE cells of Enpp2-/- embryos, distinctive large
lysosomes are fragmented. When embryos are cultured in
the presence of pharmacological inhibitors for the LPA
receptors, Rho, ROCK/Rho kinase, or LIM kinase (LIMK),
these drugs induce lysosomal defects similar to those
observed in Enpp2-/- VE cells. In addition, inhibition of Rho,
ROCK, or LIMK by electroporating their dominant
negative forms or activation of cofilin by electroporating its
constitutive active form into wild-type embryos induces the
size reduction of lysosomes in VE cells. In Enpp2-/- VE cells,
the steady-state levels of cofilin phosphorylation and actin
polymerization are reduced. Moreover, perturbations of
actin turnover dynamics by cytochalasin B or jasplakinolide
result in the defect in lysosome formation in VE cells. These
findings suggest that the control of actin turnover dynamics
through the Rho-ROCK-LIMK pathway by way of
autotaxin-LPA signaling is required for the regulatory
processes of lysosome biogenesis.
EXPERIMENTAL PROCEDURES
Animal Experiments—All the experiments using
animals were approved by the Animal Care and Use
Committee of the University of Tsukuba and performed
under its guidelines. Noon of the day on which a vaginal
plug was observed was taken as embryonic day 0.5 (E0.5).
Time pregnant ICR mice (CLEA Japan, Tokyo, Japan:
Japan SLC, Hamamatsu, Japan) were used for
pharmacological experiments and electroporation.
Generation of Enpp2-deficient Mice—A gene-targeting
vector was constructed by inserting the mouse genomic
DNA fragments flanking exons 6 and 7 of the Enpp2 gene
into a TC3 vector (a gift from Dr. Ryoichiro Kageyama,
Kyoto University, Japan), which contained a cassette of
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stop-IRES-lacZ-polyA, a neomycin-resistant gene, and a
diphtheria toxin A fragment gene. The linearized vector was
electroporated into mouse ES cells (E14 clone derived from
129/Ola), and neomycin-resistant colonies were selected by
PCR. Whether homologous recombination occurred
correctly in the selected clones was confirmed using
Southern blotting with 3’ and 5’ probes.  Chimeric mice,
obtained by injecting the ES cells into C57BL/6J blastocysts,
were mated with wild-type C57BL/6N mice. Offspring
generated by intercrosses of heterozygotes (F1 generation)
were used. Mice were genotyped by duplex PCR using the
primers,
5’-CTGCTGAAACTTAATGCACTGGAC-3’ (Enpp2
forward),
5’-TGTGTAAGTCAGGGAACAACTCTG-3’ (Enpp2
reverse),
and 5’-TGCTCCAGACTGCCTTGGGAAAAG-3’
(neo). Fragments of 473 and 336 bp were amplified from
the wild-type and targeted alleles, respectively.
Collection of Extraembryonic Coelomic Fluid (ECF)
and Western Blotting—ECF was aspirated by using a fine-
tip glass needle; about 1 µl of ECF was obtained from one
E8.5 embryo. ECF collected from 3 to 5 mouse embryos
was used for western blotting with anti-autotaxin ATX-N1
(1:1,000, TransGenic, Kumamoto, Japan; described
previously in ref. 16). The signal was detected using horse
radish peroxidase (HRP)-conjugated anti-rabbit IgG
(1:10,000; Bio-Rad, Hercules, CA, USA) and ECL PLUS
Western Blotting Detection Reagents (GE Healthcare Bio-
Sciences Corp., Piscataway, NJ, USA).
Histological Analysis—In situ hybridization and
immunohistochemistry were performed as described
previously (16). Primary antibodies used were rabbit
polyclonal anti-cofilin and anti-phosphorylated cofilin
(1:400; a kind gift of Dr. Kensaku Mizuno, Tohoku
University, Japan), rat monoclonal anti-E-cadherin (1:1,000;
a kind gift of Dr. Shinji Hirano, Kochi University, Japan), rat
monoclonal anti-LAMP1 (1:500; Developmental Studies
Hybridoma Bank, Iowa city, IA, USA), and HRP-
conjugated anti-mouse IgG (1:1,000; Chemicon, Temecula,
CA, USA). The secondary antibodies used were Cy3-
labeled anti-rabbit IgG (1:500; Jackson ImmunoResearch),
Alexa488-conjugated anti-rat IgG (1:1,000; Invitrogen,
Carlsbad, CA, USA) and Cy3-labeled anti-rat IgG (1:1000;
Jackson ImmunoResearch). Fluorescent images were
obtained using a laser scanning confocal microscope
(LSM510; Carl Zeiss, Jena, Germany).
RT-PCR—Total RNA was isolated from yolk sacs of
E7.0 to E12.5 mice using Sepasol I (Nacalai Tesque, Kyoto,
Japan). Reverse transcription and PCR were performed
using oligo(dT)12-18, Superscript II reverse transcriptase
(Invitrogen), and AmpliTaq Gold (Applied Biosystems,
Foster City, CA, USA). The PCR primers used were 5’-
GGTCAATAGCATGCAGACTG-3’ (forward) and 5’-
ACAGTTGGTCAGGTGTTCTG-3’ (reverse) for Enpp2,
and 5’-CAGGGCTGCCATTTGCAGTG-3’ (forward)
and 5’-TGGGGTCTCGCTCCTGGAAG-3’ (reverse) for
Gapdh.
Electron Microscopy—E8.5 mouse embryos were
fixed in 2.5% glutaraldehyde in phosphate-buffered saline
(PBS) at 4˚C overnight. Tissues were postfixed in buffered
osmium tetroxide and embedded in epoxy according to
standard procedures. Ultrathin sections, counterstained with
uranyl acetate and lead citrate, were examined using a
transmission electron microscope (H7000; Hitachi, Tokyo,
Japan) operated at 75 kV.
Imaging of Intracellular Vesicles—Whole embryos
with intact yolk sacs, dissected at E8.5 or cultured for 1 day
from E7.5, were incubated with 100 nM LysoTracker Red
(Invitrogen) in Dulbecco’s modified Eagle Medium
(DMEM) at 37°C for 5 min. Whole embryos were then
mounted on a glass-bottom dish (Matsunami, Osaka,
Japan), allowing observation of the yolk sac using a laser
scanning confocal microscope (LSM510; Zeiss) at room
temperature. The areas of lysosomes were measured using
Image J software. The average size of lysosomes was
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obtained from each embryo, and compared and statistically
analyzed between different experiment conditions.
Ex Vivo Whole Embryo Culture—Whole embryo
culture was performed as described previously (17, 18). In
brief, embryos were dissected at E7.5 and cultured in 100%
rat serum (Charles River, Yokohama, Japan) supplemented
with 2 mg/ml glucose in a culture bottle placed in a rotation
drum culture system (Ikemoto Rika, Tokyo, Japan) in 5%
O2, 5% CO2, and 90% N2 at 37°C for 24 h. In
pharmacological experiments, embryos were incubated
with the following reagents: 3-(4-[4-([1-(2-
chlorophenyl)ethoxy]carbonyl amino)-3-methyl-5-
isoxazolyl] benzylsulfanyl)propanoic acid (Ki16425), 10
µM (Sigma-Aldrich, St. Louis, MO, USA); (R)-phosphoric
acid mono-[2-amino-2-(3-octyl-phenylcarbamoyl)-ethyl]
ester (VPC 23019), 10 µM (Avanti Polar Lipid, Alabaster,
AL, USA); exoenzyme C3 (Clostridium botulinum), 20
µg/ml (Calbiochem, Darmstadt, Germany); (S)-(+)-2-
methyl-1-[(4-methyl-5-
isoquinolynyl)sulfonyl]homopiperazine dihydrochloride
(H1152), 0.1 µM (Calbiochem); 1-[6-[[(17β)-3-
methoxyestra-1,3,5(10)-trien-17-yl]amino]hexyl]-1H-
pyrrole-2,5-dione (U-73122), 10 µM (Sigma-Aldrich); 2-
(4-morpholinyl)-8-phenyl-1(4H)-benzopyran-4-one
hydrochloride (LY294002), 10 µM (Sigma-Aldrich);
pertussis toxin, 0.5 µg/ml (Calbiochem); 2-(2’-amino-3’-
methoxy)-flavone (PD98059), 10 µM (Calbiochem); (R)-
(+)-trans-N-(4-pyridyl)-4-(1-aminoethyl)-
cyclohexanecarboxamide, 2HCl  (Y-27632), 0.1-1 µM
(Calbiochem);  1-(1-hydroxy-5-
isoquinolinesulfonyl)homopiperazine monohydrochloride
(Hydroxyfasudil), 1-10 µM (Sigma-Aldrich); 1-phenyl-
1,2,3,4-tetrahydro-4-hydroxypyrrolo[2.3-b]-7-
methylquinolin-4-one  (blebbistatin), 10 µM (Toronto
Research Chemicals, North York, On, Canada);
cytochalasin B, 0.3 µM (Calbiochem); jasplakinolide, 10
nM (Calbiochem); S3 and RV peptides, 15 µg/ml (a kind
gift of  Dr. Kensaku Mizuno, Tohoku University).
Phalloidin Staining and Quantitation—For phalloidin
staining, embryos were fixed with 4% paraformaldehyde in
PBS at 37°C for 15 min. Whole embryos or cryostat
sections were incubated with 0.2 U/ml Alexa488- or Alexa-
546-conjugated phalloidin (Invitrogen) for 60 min. To
compare fluorescence signal intensity, confocal images of
yolk sacs in cryostat sections were collected with all laser
settings constant. Fluorescence signal intensity was obtained
using Zeiss LSM510 software and analyzed statistically
using the t-test.
Electroporation of Whole Embryos—Whole embryos
were dissected at E7.5 and transferred to Hanks’ Balanced
Salt Solution (HBSS; Invitrogen) kept at 37°C. One
embryo was inserted into a small hole of an agarose mold
(2% agarose/PBS, 7 mm square) placed in HBSS. The
solution bathing the embryos was then replaced with HBSS
containing 2 mg/ml DNA. Three square electric pulses (30
V, 50 ms duration, 1 pulse/s) were delivered to the agarose
mold using an electroporator (CUY21; Nepa Gene, Chiba,
Japan) and a 10-mm electrode (CUY650P10; Nepa Gene).
After electroporation, the embryo was rinsed with HBSS
and cultured as described in the previous section. Dominant
negative (DN) and constitutive active (CA) forms of RhoB,
ROCK, LIMK, and cofilin were kind gifts of Dr. Toshio
Hirano (Osaka University), Dr. Shu Narumiya (Kyoto
University), and Dr. Kensaku Mizuno (Tohoku University).
DN-RhoB [RhoB (T19N)] and CA-RhoB [RhoB
(G14V)] (19) were subcloned into the pEGFP-IRES2
vector (Clontech, Mountain View, CA, USA). DN-ROCK
(KD-IA) and CA-RCOK (Δ3) (20) in the pCAGGS
expression vector were fused to EGFP at their N-termini.
DN-LIMK [LIMK1 (D460A)] and CA-LIMK [LIMK1
(T508EE)] (21) were subcloned into the pEGFP-IRES2
vector. DN-cofilin [cofilin (S3E)] and CA-cofilin [cofilin
(S3A)] (22,23) were fused to YFP at their N-termini in the
expression vector derived from pEGFP-C1 (Clontech).
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RESULTS
Formation of Large Lysosomes is Impaired in Enpp2-/-
VE Cells—Enpp2 knockout mice were generated by
disrupting the exons that encode the enzyme catalytic
domain (Fig. 1A and B). Enpp2 mRNA and protein were
completely absent in Enpp2-/- mice (Fig. 1C and D). Whilst
heterozygous mice were apparently normal and fertile,
Enpp2-/- embryos died at E9.5 owing to angiogenic defects
in the yolk sac (Fig. 1E and F), as reported previously (9, 10).
To elucidate the roles of Enpp2 in early development, its
expression before E9.5 was examined.  Enpp2 mRNA was
first detectable in the embryonic ectoderm at the late
cylinder and primitive streak stages (E6.0 to E6.5) (Fig. 2A).
From E7.5 to E8.5, strong signals were detected in the yolk
sac, especially in VE cells (Fig. 2A). RT-PCR indicated that
Enpp2 mRNA was highly expressed in the yolk sac
between E7.5 and E9.5 (Fig. 2B).
 Thus, we focused on yolk sac VE cells.  While searching
for possible defects using immunohistochemistry, we
noticed intriguing changes in the intracellular vesicles in
Enpp2-/- VE cells. Because VE cells vigorously take up
maternal proteins including IgG from the apical surface,
endocytic vesicles can be visualized simply by
immunostaining for mouse IgG. Control VE cells had large
IgG-containing vesicles, whereas Enpp2-/- VE cells had
smaller punctate vesicles (Fig. 3A, top). Electron
microscopy demonstrated that control VE cells had a few
large vesicles in the apical portion, whereas Enpp2-/- VE
cells had numerous smaller vesicles (Fig. 3A, middle). To
examine lysosomes  in VE cells, we stained whole embryos
with LysoTracker Red, a fluorescent dye that selectively
accumulates in acidic organelles, and observed lysosomes
in VE cells using a confocal microscope. This analysis
revealed that lysosomes became significantly smaller and
the number of lysosomes significantly increased in Enpp2-/-
VE cells (Fig. 3A-B). Similarly, immunostaining with a
lysosome marker, LAMP1, also revealed that lysosomes
were smaller in Enpp2-/- VE cells (Fig. S1). These findings
indicate that Enpp2-/- embryos had defects in the formation
of large lysosomes, which are one of the distinctive features
of VE cells.
LPA Receptors are Required to Form Large Lysosomes
in VE Cells—We next examined the downstream
signaling pathways of autotaxin using an ex vivo whole
embryo culture system. Whole embryo culture is a well-
established system that has been proved to be useful for
studying normal development as well as assessing
teratogenicity and gene functions (17, 18). When E7.5 wild-
type embryos were cultured for 1 day, the appearances of
the yolk sac and embryos were indistinguishable from those
of the in-utero-grown E8.5 wild-type embryos (Fig. S2A).
In addition, when E7.5 Enpp2-/- embryos were cultured for 1
day, head cavity was formed as seen in the in-utero-grown
E8.5 Enpp2-/- embryos (Fig. S2A). Furthermore, the
lysosome size in VE cells was reduced in the cultured
Enpp2-/- embryos compared with that in the cultured wild-
type embryos, in the same way and to the same extent that
the lysosome size in VE cells was reduced in the Enpp2-/-
embryos in vivo (Fig. S2A-B). These results indicate that a
whole embryo culture system faithfully mimics in vivo
development of wild-type and Enpp2-/- embryos, thus
providing a feasible tool to test the effects of
pharmacological manipulation of VE cells.
We thus set out to test the effects of the inhibitors of the
LPA signaling pathway. In this study, we used subtoxic
concentrations of drugs, which were carefully
predetermined in preliminary tests as not inducing
developmental retardation or cardiac arrest (data not shown).
First, LPA and S1P receptor antagonists were tested. When
E7.5 wild-type embryos were cultured for 1 day with 10
µM Ki16425, an LPA1/LPA3 antagonist (24), lysosomes
became significantly smaller (Fig. 4A-B). In contrast, 10
µM VPC23019, an S1P1/S1P3 antagonist (25), did not
induce size reduction of lysosomes (Fig. 4A-B), although
the drug must have effectively acted on the yolk sac because
it induced angiogenic defects (data not shown). These
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findings indicate that LPA receptor signaling is required to
form large lysosomes in VE cells.
Rho-ROCK Pathway is Required to Form Large
Lysosomes in VE Cells—LPA receptors are coupled to
several signaling pathways through distinct G proteins; the
major pathways include G12/13-Rho-ROCK, Gi-
phosphatidylinositol 3-kinase (PI3K)-Rac, Gi-Ras-MAPK,
and Gq-phospholipase C (PLC) (4, 5, 7). To determine
which pathway is required in the downstream of autotaxin,
we tested selective inhibitors for each pathway. Treatment
of embryos with either a Rho inhibitor, Clostridium C3
exoenzyme (20 µg/ml), or a ROCK inhibitor, H1152 (0.1
µM), resulted in a significant size reduction of lysosomes
(Fig. 4C, Fig. S3A). Other ROCK inhibitors,
hydroxyfasudil (1-10 µM) and Y-27632 (1 µM), were also
effective (Fig. S4). In contrast, none of the inhibitors of Gi
(pertussis toxin, 0.5 µg/ml), PLC (U-73122, 10 µM), PI3K
(LY294002, 10 µM), or MAPK (PD98059, 10 µM) had
any effect on the size of lysosomes (Fig. 4C, Fig. S3A).
These findings indicate that the Rho-ROCK pathway plays
an important role in the downstream of autotaxin-LPA
signaling in the formation of large lysosomes in VE cells.
LIMK Pathway is Required to Form Large Lysosomes
in VE Cells—The main downstream targets of ROCK are
LIMK and myosin light chain (MLC). ROCK
phosphorylates and activates LIMK, which in turn
phosphorylates and inactivates cofilin, a protein that
stimulates actin filament disassembly (23, 26, 27). ROCK
also induces MLC phosphorylation directly and indirectly
through the inhibition of myosin phosphatase by
phosphorylating its myosin-binding subunit (28). We tested
which pathway is the main target of ROCK in this system.
When mouse embryos were cultured with a myosin II
inhibitor, blebbistatin (10 µM), the lysosome size was not
changed (Fig. 4D, Fig. S3B).  Thus, we next examined the
effect of a cell-permeable LIMK inhibitor, S3 peptide,
which contains the N-terminal 16 amino acid sequence of
cofilin and the cell-permeable sequence of penetratin (29).
As a negative control, RV peptide, which contains the
reverse sequence of cofilin and the cell-permeable sequence
of penetratin, was used (29). When mouse embryos were
cultured with 15 µg/ml of S3 or RV peptide, S3 peptide
inhibited cofilin phosphorylation (Fig. S5) and resulted in
the size reduction of lysosomes in VE cells (Fig. 4E, Fig.
S3B). These findings indicate that the LIMK-cofilin
pathway is the main target of ROCK and responsible for the
formation of large lysosomes in VE cells.
If LIMK activity is reduced in Enpp2-/- VE cells, it would
be expected to decrease phosphorylation of cofilin (23, 26,
27). We thus examined phosphorylation levels of cofilin by
immunostaining of VE cells with anti-phosphorylated
cofilin or anti-total-cofilin antibody. Quantitation of the
staining intensity revealed that the steady-state level of
cofilin phosphorylation was significantly decreased without
affecting the cofilin levels in Enpp2-/- VE cells (Fig. 5A-B).
This finding of decreased cofilin phosphorylation strongly
supports the supposition that LIMK activity was decreased
in Enpp2-/- VE cells.
Actin Filaments are Depolymerized in Enpp2-/- VE
Cells—Reduced phosphorylation of cofilin activates cofilin,
thereby leading to depolymerization and severance of the
actin filaments (27). To examine whether this happens in
Enpp2-/- VE cells, we stained whole embryos with
Alexa488-phalloidin and visualized actin filaments in VE
cells using a confocal microscope. As predicted from the
above findings, the amounts of polymerized actin (observed
as the phalloidin staining intensity in confocal microscopy)
appeared to be reduced throughout Enpp2-/- VE cells
compared with those in the wild-type VE cells (Fig. 6A). To
exclude the possibility that the differences in the staining
intensity resulted from the difference in the Alexa488-
phalloidin permeability, we performed the staining using the
sections of the yolk sac. In this experiment, to compare the
signals precisely, we obtained the fluorescence images
using a confocal microscope with constant scanning
parameters. As shown in Figure 6B, phalloidin staining
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intensity was lower in the Enpp2-/- VE cells than that in the
wild-type cells.  Statistical analysis of the fluorescence
intensity in the yolk sac sections indicated that the amounts
of polymerized actin were significantly lower in Enpp2-/-
VE cells than those in wild-type VE cells (Fig. 6C).
Next, we examined whether actin polymerization in VE
cells were regulated by the LPA receptor-Rho-ROCK-
LIMK pathway. We cultured wild-type mouse embryos
with the inhibitors used in the above experiments for 1 day
and performed phalloidin staining. As a result, all the drugs
that induced the reduction of the lysosome size (Ki16425,
C3 exoenzyme, H1152, and S3 peptide) resulted in
reductions in phalloidin staining in VE cells (Fig. 6D). Thus,
the amount of polymerized actin was reduced in Enpp2-/-
VE cells most likely as a result of the decrease in the LPA
receptor-Rho-ROCK-LIMK signaling.
The above findings suggest the possibility that actin
filaments regulate lysosome formation in VE cells. To test
this, we examined directly whether perturbation of actin
cytoskeleton dynamics causes defects in lysosomes. First, to
induce actin-depolymerized conditions similar to those in
Enpp2-/- VE cells, E7.5 embryos were cultured with 0.3 µM
cytochalasin B for 1 day. This treatment led to a significant
reduction in lysosome size in VE cells (Fig. 7A), suggesting
that actin polymerization is required to form large
lysosomes. Moreover, when the embryos cultured with
cytochalasin B for 1 day were observed after the drug was
removed, the lysosome sizes in VE cells returned to normal
over time (Fig. 7B). This finding indicates that the effects of
cytochalasin B on lysosomes were reversible and not
merely cytotoxic actions. Reversely, stabilization of actin
filaments by culturing embryos with 10 nM jasplakinolide
also induced reduction in lysosome size (Fig. 7A). Thus,
actin depolymerization is also required for lysosome
formation. Taken together, these findings suggest that the
dynamic regulation of actin turnover is required for the
formation of large lysosomes in VE cells, whilst actin
filaments tend to shift to the net depolymerization owing to
the activation of cofilin as a result of steady-state
dephosphorylation of cofilin in Enpp2-/- VE cells.
Electroporation of Dominant-Negative Forms of Rho,
ROCK, or LIMK Induces Lysosomal Defects in VE
Cells—Finally, we tested the validity of our
pharmacological experiments using a molecular approach:
we overexpressed DN or CA forms of Rho, ROCK,
LIMK, or cofilin in VE cells, and observed the changes in
lysosome size. For this purpose, we developed a method to
introduce exogenous DNAs into VE cells by
electroporation (see details in EXPERIMENTAL
PROCEDURES). The DN forms used were RhoB
(T19N), ROCK (KD-IA), LIMK1 (D460A), and cofilin
(S3E), whereas the CA forms used were RhoB (G14V),
RCOK (Δ3), LIMK1 (T508EE), and cofilin (S3A) (19-23).
To label the electroporated cells, Rho and LIMK cDNAs
were subcloned into an pEGFP-IRES vector, whereas
ROCK and cofilin were fused to EGFP and YFP,
respectively.
We first examined whether inhibition of the Rho-
ROCK-LIMK pathway by electroporating their DN forms
induced depolymerization of actin filaments. After E7.5
whole embryos were dissected and electroporated, they
were cultured for 1 day using an ex vivo whole embryo
culture system, and subsequently stained with Alexa546-
phalloidin. When EGFP alone was electroporated,
phalloidin staining intensity was not changed (Figure 8A),
indicating that neither electroporation nor EGFP
overexpression affected actin polymerization. In contrast,
electroporation of DN-Rho, DN-ROCK, or DN-LIMK
induced actin depolymerization (Figure 8A), indicating that
the Rho-ROCK-LIMK pathway was inhibited by the
electroporation of these expression constructs.
Next, we examined the effects of Rho-ROCK-LIMK
inhibition on lysosome formation using LysoTracker Red
staining. Electroporation of EGFP alone showed no
obvious effects on lysosome size, whereas electroporation
of DN-Rho, DN-ROCK, or DN-LIMK induced size
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reduction of lysosomes in VE cells (Figure 8B-C). In severe
cases (10%-20%), LysoTrakcer Red staining disappeared
(data not shown, Figure 8C). Inhibition of Rho-ROCK-
LIMK pathway results in the decrease of cofilin
phosphorylation, thus leading to activation of cofilin. To
mimic this, we used the S3A mutant of cofilin, which is
constitutively active and cannot be phosphorylated.
Electroporation of cofilin (S3A) induced the size reduction
of lysosomes, although the steady state levels of phalloidin-
staining intensity were not apparently changed (Figure 8).
Thus, these findings demonstrate that inhibition of the Rho-
ROCK-LIMK-cofilin signaling pathway led to defects in
the formation of large lysosomes in VE cells.
Next, we examined the effects of Rho-ROCK-LIMK
activation on lysosome formation. When the CA forms of
Rho or LIMK were electroporated, actin polymerization
was increased (Figure S6A), indicating that Rho and LIMK
were activated in VE cells by electroporation of these CA
constructs. CA-Rho and CA-LIMK led to the reduction of
lysosome size in VE cells (Figure S6B-C), suggesting that
activation of Rho or LIMK resulted in the defects in
lysosome formation. When CA-ROCK was electroporated,
VE cells became severely deformed and were unsuitable
for further examination (data not shown). We thus excluded
CA-ROCK electroporation from the analysis. Activation of
the Rho-ROCK-LIMK pathway phosphorylates cofilin,
thereby leading to inactivation of cofilin. To induce this state,
we used the S3E mutant of cofilin, which mimics the
phosphorylated state of cofilin. When cofilin (S3E) was
electroporated, lysosomes became smaller, although the
changes in the steady state levels of phalloidin staining were
not apparent (Figure S6B-C). These findings suggest that
overactivation of the Rho-ROCK-LIMK-cofilin pathway
led to the defects in lysosome formation. Thus, the balance
between actin polymerization and depolymerization was
important to maintain the large size of lysosomes in VE
cells, compatible with our findings that both cytochalasin B
and jasplakinolide led to lysosomeal defects.
DISCUSSION
In this study, we demonstrated that autotaxin-LPA
signaling is required to form distinctive large lysosomes in
yolk sac VE cells. We provided the evidence that
constitutive activation of LPA receptors as a result of high
Enpp2 expression in the yolk sac VE cells, starting from
E7.5, is required for the formation of large lysosomes. We
also showed that actin turnover dynamics regulated by the
Rho-ROCK-LIMK pathway play a central role in the
downstream pathway.
We found linkage between autotaxin-LPA signaling and
lysosome biogenesis. Although little is known about the
relationship between LPA and organelle biogenesis,
multiple roles of Rho GTPases, the main downstream
effectors of LPA signaling, in endocytic trafficking have
been reported (30, 31). For example, RhoB and RhoD,
GTPases known to associate with endosomes, control
endocytic trafficking by regulating actin polymerization (30
31). The interaction of RhoB and mDia2 on endosomes
regulates vesicle trafficking by controlling actin dynamics
(32). Our findings demonstrate that inhibition of Rho and its
downstream signaling pathway by pharmacological
blockers or electroporation of DN constructs led to
fragmentation of lysosomes in VE cells. Thus, our results
suggest that extracellular production of LPA by autotaxin in
mouse embryos controls endocytic vesicle trafficking
through the Rho pathway to form large lysosomes in yolk
sac VE cells. This notion is compatible with a previous
argument that the phenotypes of Enpp2-/- embryos are
similar to those of embryos lacking Gα12 and Gα 13, the key
mediators for the Rho pathway (10, 33).
We also showed linkage between autotaxin and actin
dynamics. Although it is well known that LPA regulates
actin cytoskeleton rearrangements, ours is the first study to
indicate that autotaxin controls the levels of actin
polymerization in vivo. Because autotaxin protein was
detected in the ECF (Figure 1D), autotaxin should produce
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LPA and activate LPA receptors constantly in mouse
embryos, thereby controlling actin dynamics required for
large lysosome formation in VE cells. In addition to the
well-studied roles of actin in endocytosis (34-36),
accumulating evidence has suggested that actin directly
regulates vesicle fusion and transport in the endocytic
pathway (34, 35). For example, treatment of cells with actin-
depolymerizing drugs induced defects in the transport from
late endosomes to lysosomes in mammalian cells (37, 38).
In addition, in vitro fusion assays showed that actin
facilitated fusion between phagosomes and late endosomes
and between late endosomes themselves (39). Thus,
autotaxin appears to promote vesicle fusion and/or transport
processes from endosomes to lysosomes in VE cells. Future
studies are required to examine whether and how autotaxin-
LPA controls endocytic vesicle trafficking.
VE cells and yeast have many common features in
endocytic vesicles. First, both are active in
endocytosis/digestion and have large lysosomes (vacuoles).
Second, Rho activity is required for lysosome (vacuole)
formation: two Rho GTPases, Rho1p and Cdc42p, are
enriched on vacuole membranes and required for docking
and fusion of vacuoles in yeast (40), whereas in VE cells,
C3 exotoxin and DN-Rho induced fragmentation of
lysosomes. Third, actin is involved in lysosome formation:
actin was bound to vacuoles, and vacuole fusion was
inhibited by jasplakinolide or an actin-destabilizing reagent,
latrunculin, in yeast (41), whereas cytochalasin B or
jasplakinolide inhibited lysosome formation in VE cells.
Therefore, there seems to be a common cellular machinery
to maintain large lysosomes in these cells. We tried to
enlarge lysosomes in cultured cell lines by treating them
with LPA, by overexpressing Enpp2, or by transfecting CA
forms of Rho, ROCK, or LIMK, but we could not see any
changes in lysosome size (S. K. and M. M., unpublished
observation). Thus, to make such large lysosomes
(vacuoles) as observed in VE cells and yeast, sufficient
amounts of certain cellular components required for
lysosome biogenesis may be necessary in addition to the
activation of Rho signaling and actin dynamics. Conversely,
we tried to reduce the size of lysosomes in cultured cell lines
by treating them with LPA antagonists or by transfecting
DN forms of Rho, ROCK, or LIMK. However, we did not
see any apparent changes of lysosome size in VE cells (S. K.
and M. M., unpublished observation), although we could
not evaluate the lysosome size correctly because lysosomes
in cultured cell lines were much smaller than those in VE
cells.
In summary, we have found a novel function of
autotaxin-LPA signaling in the regulation of lysosome
biogenesis. Further studies are required to examine whether
autotaxin-LPA controls actin dynamics and lysosome
formation in other Enpp2-expressing cells, exactly which
processes in lysosome biogenesis are regulated by
autotaxin-LPA, and what biological significance can be
attributed to the autotaxin-LPA signaling in lysosome
formation. It is also worth noting that yolk sac VE cells
provide a useful system to study the cellular and molecular
mechanisms of vesicle trafficking and biogenesis in
mammalian cells because of the simple anatomy of the yolk
sac, the large size and easy labeling of endocytic vesicles,
and their accessibility for pharmacological manipulation
and a molecular approach.  
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FIGURE LEGENDS
FIGURE 1. Targeted disruption of the murine Enpp2 gene.  A, scheme of targeting strategy. Part of exon 6 and the entirety
of exon 7 of the Enpp2 gene were replaced with a stop-IRES-lacZ-polyA-pgk-Neo cassette.  Abbreviations: DTA, diphtheria
toxin A fragment; H, HpaI; P, PvuII, S, SacI. B, Southern blotting of HpaI-, PvuII-, or SacI-digested genomic DNA
hybridized with 5’, 3’, or neo probes verified the germline transmission of the correctly targeted Enpp2 allele. Closed and open
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arrowheads indicate the bands for wild-type and targeted alleles, respectively. The band sizes of the wild-type and targeted
alleles are 8.6 kb and 6.8 kb for the 5’ probe, and 7.0 kb and 4.5 kb for the 3’ probe, respectively. C, RT-PCR analysis revealed
that Enpp2 mRNA was absent in the Enpp2-/- embryos.  RT(-) indicates a control reaction without reverse transcriptase. D,
western blot revealed that autotaxin protein was absent in the extraembryonic coelomic fluid of the E8.5 Enpp2-/- embryos. WT
indicates Enpp2+/+ or Enpp2+/- control embryos (denoted in the same way hereafter). E, appearance of the E9.5 yolk sac. Large
vitelline vessels formed in the control (black arrow) but not in the Enpp2-/- yolk sac, in which red blood cells precipitated (white
arrows). F, gross appearance of the E9.5 embryos. Most Enpp2-/- embryos were much smaller than the controls and did not
undergo embryonic turning. The arrow indicates the head cavity in Enpp2-/- embryos. Scale bar represents 1.0 mm.
FIGURE 2. Enpp2 mRNA is highly expressed in yolk sac VE cells.  A, in situ hybridization of Enpp2. Strong expression
was observed in the embryonic ectoderm (ect) at E6.0-E6.5, in the yolk sac (ys) at E7.5-E8.5, and in the head fold (hf) and
somites (arrowheads) at E8.5. Transverse sections (bottom) showed robust expression in the visceral endoderm (ve) of the yolk
sac. Abbreviations: epc, ectoplacental cone; hp, head process; mes, extraembryonic mesoderm. Scale bar represents 190 µm
(top left), 210 µm (top right), 400 µm (middle left), 450 µm (middle right), 270 µm (bottom left), and 40 µm (bottom right). B,
RT-PCR of Enpp2 mRNA in the E7.0-E12.5 yolk sac. RT(-) indicates a control reaction without reverse transcriptase.
Glyceraldehyde-3-phosphate dehydrogenase (Gapdh) was used as a control.
FIGURE 3. Formation of large lysosomes is impaired in the yolk sac VE cells of Enpp2-/- embryos.  A, IgG
immunostaining (top), electron microscopy (middle), and LysoTracker Red staining (bottom) of the E8.5 yolk sac.
Immunostaining with anti-mouse IgG antibody detects endocytic vesicles in the VE cells (ve). IgG-containing vesicles in
Enpp2-/- VE cells were smaller than those in the wild-type (WT) cells. Electron microscopy showed  a few large vesicles in the
apical portion of the wild-type VE cells (arrows), whereas numerous vesicles of smaller size were seen in the Enpp2-/- cells
(arrows). Confocal microscopic images of the yolk sac showed that LysoTracker Red-positive lysosomes were decreased in
size but increased in number in the Enpp2-/- VE cells compared with those in  the control. The yellow dotted lines indicate the
boundary of VE cells. Scale bar represents 20 µm (top), 1.7 µm (middle), and 12 µm (bottom). Abbreviations: bc, blood cells;
mv, microvillus; n, nucleus. B, the size and number of lysosomes in VE cells. Lysosomes were significantly decreased in size
and increased in number in Enpp2-/- VE cells. The values are the means ± S.E.M. (***P < 0.001; unpaired t-test). The number
of embryos examined is shown in each column.
FIGURE 4. Blockade of the LPA receptor-Rho-ROCK-LIMK pathway induces defects in lysosome formation.  A,
confocal microscopic images of the yolk sac stained with LysoTracker Red. After E7.5 wild-type embryos were cultured with
an LPA1/LPA3 antagonist (10 µM Ki16425) or an S1P1/S1P3 antagonist (10 µM VPC23019) for 1 day, LysoTracker Red
staining was performed. Ki16425 induced the size reduction of lysosomes in the VE cells, whereas VPC23019 was ineffective.
Scale bar represents 6 µm. B-E, quantitation of the lysosome size in the embryos cultured with the indicated inhibitors.
Treatment of wild-type embryos with Ki16425 (Ki) as well as the inhibitors of Rho (20 µg/ml C3 exoenzyme), ROCK (0.1
µM H1152), or LIMK (15 µg/ml S3 peptide) resulted in significant size reduction in lysosomes when compared with the
controls, whereas treatment with VPC23019 (VPC) and the inhibitors for Gi (0.5 µg/ml pertussis toxin (PTX)), PLC (10 µM
U-73122), PI3K (10 µM LY294002), MAPK (10 µM PD98059), or myosin II (10 µM blebbistatin) showed no effect on the
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size of lysosomes. The values are the means ± S.E.M. [*P < 0.05, **P < 0.01; ANOVA with a Tukey-Kramer post-hoc test
(B-C), unpaired t-test (D-E)]. The number of embryos examined is shown in each column.
FIGURE 5. Phosphorylation of cofilin is decreased in Enpp2-/- VE cells.  A, confocal microscopic images of the yolk sac
stained with anti-phosphorylated-cofilin (P-cofilin) or anti-total-cofilin (red). E-cadherin immunostaining (E-cad, green) shows
the cell boundaries. Scale bar represents 4 µm. B, intensity of the immunostaining. Staining intensity for phosphorylated cofilin,
measured in 3 different regions (36.6 x 36.6 µm) per embryo, was significantly reduced in Enpp2-/- VE cells, whereas staining
intensity of total cofilin and E-cadherin was unchanged. The values are the means ± S.E.M. (*P < 0.05; unpaired t-test). The
number of embryos examined is shown in each column.
FIGURE 6. Polymerized actin is reduced in Enpp2-/- VE cells.  A, confocal microscopic images of the VE cells stained with
Alexa488-phalloidin. Top, middle, and bottom panels show the superficial, intermediate, and deep layers of the apical portion
of the VE cells, respectively.  Phalloidin staining was reduced throughout all layers in Enpp2-/- VE cells.  B, Alexa488-
phalloidin staining of the cryostat sections of E8.5 yolk sacs. The apical portion is at the top. Bottom figures show higher power
images of VE cells. Abbreviations: bc, blood cells; ve, visceral endoderm cells. C, the cumulative plot shows that phalloidin
staining intensity was lower in Enpp2-/- VE cells than that in wild-type VE cells.  D, Phalloidin staining after inhibitor treatment.
After wild-type embryos were cultured in the presence of the indicated inhibitors for 1 day, Alexa488-phalloidin staining was
performed. Treatment with Ki16425, C3 exoenzyme, H1152, or S3 peptide, but not with VPC23019, led to the reduction of
phalloidin staining in VE cells. Scale bar represents 6 µm (A, D), 40 µm (B, top), and 4 µm (B, bottom).
FIGURE 7. Actin inbibitors induce defects in lysosome formation.  A, quantitation of the lysosome size in the embryos
cultured with the indicated inhibitors. After E7.5 wild-type embryos were cultured with 0.3 µM cytochalasin B (CB, a cell-
permeable inhibitor of actin polymerization) or 10 nM jasplakinolide (Jasp, a cell-permeable stabilizer of actin filament) for 1
day, LysoTracker Red staining was performed. Both actin inhibitors induced the size reduction in lysosomes in VE cells.  B,
recovery of the lysosome size after washout of cytochalasin B. After E7.5 wild-type embryos were cultured with 0.3 µM
cytochalasin B for 1 day, the drug was removed. LysoTracker Red staining was performed 5, 30, and 60 min after washout of
cytochalasin B. The lysosome size increased over time. The values are the means ± S.E.M. (*P < 0.05, **P < 0.01, ***P <
0.001; ANOVA with a Tukey-Kramer post-hoc test). The number of embryos examined is shown in each column.
FIGURE 8. Electroporation-mediated inhibition of the Rho-ROCK-LIMK pathway induces lysosomal defects in VE
cells. A-B, confocal microscopic images of the VE cells stained with Alexa546-phalloidin (A) or LysoTracker Red (B). After
whole embryos were electroporated with the expression constructs for the indicated molecules and cultured for 1 day, they
were stained with Alexa546-phalloidin or LysoTracker Red. To identify electroporated cells, EGFP was co-expressed by
subcloning into a pEGFP-IRES2 vector or making EGFP (or YFP) fusion proteins. Asterisks indicate electroporated cells.
DN-Rho, DN-ROCK, or DN-LIMK induced the decrease in phalloidin staining, whereas elecroporation of EGFP alone had
no effect (A). In the VE cells expressing DN-Rho, DN-ROCK, DN-LIMK, or cofilin (S3A), lysosomes became smaller or
LysoTracker Red staining disappeared. The cells that showed severe morphological abnormalities were excluded from the
analyses. Scale bars indicate 10 µm. C, summary of the effects of DN-Rho, DN-ROCK, DN-LIMK, and cofilin (S3A) on
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lysosome size. The VE cells possessing at least 1 lysosome with an area of more than 40 µm2 were categorized as “normal,”
whereas those possessing only small lysosomes (area smaller than 40 µm2) were categorized as “small.” The cells showing no
visible LysoTracker Red staining were categorized as having “no signal.” The numbers of the VE cells examined are shown
on the right.
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